ReShape Lifesciences EPS - Earnings per Share 2015-2024 | RSLS
ReShape Lifesciences eps - earnings per share from 2015 to 2024. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| ReShape Lifesciences Annual EPS | |
|---|---|
| 2024 | $-345.75 |
| 2023 | $-2,771.75 |
| 2022 | $-158,284.90 |
| 2021 | $-420,014.50 |
| 2020 | $-402,616.30 |
| 2019 | $-5.03 |
| 2018 | $-19.64 |
| 2017 | $-2.08 |
| 2016 | $-4.85 |
| 2015 | $-27.14 |
| 2014 | $-18.61 |
| ReShape Lifesciences Quarterly EPS | |
|---|---|
| 2024-12-31 | $-49.98 |
| 2024-09-30 | $-77.75 |
| 2024-06-30 | $-87.21 |
| 2024-03-31 | $-130.81 |
| 2023-12-31 | $2,549.46 |
| 2023-09-30 | $-1,484.00 |
| 2023-06-30 | $-1,569.77 |
| 2023-03-31 | $-2,267.44 |
| 2022-12-31 | $-51,700.59 |
| 2022-09-30 | $-39,258.72 |
| 2022-06-30 | $-35,537.79 |
| 2022-03-31 | $-31,787.79 |
| 2021-12-31 | $-191,816.80 |
| 2021-09-30 | $-75,581.39 |
| 2021-06-30 | $-62,500.00 |
| 2021-03-31 | $-90,116.28 |
| 2020-12-31 | $-268,894.70 |
| 2020-09-30 | $-95,930.23 |
| 2020-06-30 | $-37,790.70 |
| 2020-03-31 | $-0.68 |
| 2019-12-31 | $1.69 |
| 2019-09-30 | $-0.61 |
| 2019-06-30 | $-2.52 |
| 2019-03-31 | $-3.59 |
| 2018-12-31 | $-14.89 |
| 2018-09-30 | $-3.47 |
| 2018-06-30 | $-0.57 |
| 2018-03-31 | $-0.71 |
| 2017-12-31 | $-0.60 |
| 2017-09-30 | $-0.55 |
| 2017-06-30 | $-0.46 |
| 2017-03-31 | $-0.47 |
| 2016-12-31 | $13.98 |
| 2016-09-30 | $-5.46 |
| 2016-06-30 | $-7.15 |
| 2016-03-31 | $-6.22 |
| 2015-12-31 | $0.00 |
| 2015-09-30 | $-6.21 |
| 2015-06-30 | $0.00 |
| 2014-12-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.004B | $0.008B |
| ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and services which manage and treat obesity and metabolic disease. ReShape Lifesciences Inc., formerly known as Obalon Therapeutics, is based in SAN CLEMENTE, CA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $197.198B | 86.37 |
| Thermo Fisher Scientific (TMO) | United States | $152.338B | 18.43 |
| Edwards Lifesciences (EW) | United States | $44.711B | 29.32 |
| Alcon (ALC) | Switzerland | $42.764B | 28.90 |
| IDEXX Laboratories (IDXX) | United States | $41.538B | 47.74 |
| DexCom (DXCM) | United States | $33.459B | 51.72 |
| IQVIA Holdings (IQV) | United States | $24.313B | 13.62 |
| STERIS (STE) | Ireland | $24.189B | 26.67 |
| Mettler-Toledo (MTD) | United States | $24.167B | 28.74 |
| Waters (WAT) | United States | $21.326B | 30.09 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.973B | 0.00 |
| Hologic (HOLX) | United States | $13.854B | 15.05 |
| Sysmex ADR (SSMXY) | Japan | $10.783B | 30.59 |
| Penumbra (PEN) | United States | $10.558B | 82.87 |
| Masimo (MASI) | United States | $8.526B | 31.45 |
| Globus Medical (GMED) | United States | $8.067B | 19.22 |
| Glaukos (GKOS) | United States | $5.541B | 0.00 |
| Teleflex (TFX) | United States | $5.433B | 8.97 |
| TransMedics (TMDX) | United States | $4.347B | 94.51 |
| Integer Holdings (ITGR) | United States | $4.244B | 22.24 |
| PROCEPT BioRobotics (PRCT) | United States | $3.238B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.400B | 14.29 |
| Veracyte (VCYT) | United States | $2.190B | 30.74 |
| Elekta AB (EKTAY) | Sweden | $1.975B | 17.76 |
| Nihon Kohden (NHNKY) | Japan | $1.848B | 21.20 |
| Alphatec Holdings (ATEC) | United States | $1.801B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.431B | 0.00 |
| Artivion (AORT) | United States | $1.247B | 116.84 |
| Pulse Biosciences (PLSE) | United States | $1.139B | 0.00 |
| OPKO Health (OPK) | United States | $1.039B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.020B | 5.42 |
| SiBone (SIBN) | United States | $0.792B | 0.00 |
| IRadimed (IRMD) | United States | $0.668B | 33.90 |
| RxSight (RXST) | United States | $0.651B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.648B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.615B | 13.44 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.592B | 9.21 |
| Delcath Systems (DCTH) | United States | $0.572B | 0.00 |
| AxoGen (AXGN) | United States | $0.515B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.513B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.484B | 12.88 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.450B | 0.00 |
| NeuroPace (NPCE) | United States | $0.415B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.394B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.383B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.351B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.273B | 0.00 |
| Neuronetics (STIM) | United States | $0.261B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.227B | 13.76 |
| Alpha Tau Medical (DRTS) | Israel | $0.216B | 0.00 |
| 908 Devices (MASS) | United States | $0.195B | 0.00 |
| CVRx (CVRX) | United States | $0.181B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.180B | 0.00 |
| Inogen (INGN) | United States | $0.178B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.178B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.175B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.173B | 0.00 |
| Accuray (ARAY) | United States | $0.169B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.164B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.156B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.108B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.098B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.20 |
| InspireMD (NSPR) | Israel | $0.076B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.065B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.065B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.053B | 16.25 |
| Positron (POSC) | United States | $0.053B | 0.00 |
| Hyperfine (HYPR) | United States | $0.051B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Spectral AI (MDAI) | United States | $0.037B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.033B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.85 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |